SCHEMBL5457650

SCHEMBL5457650

COc1ccccc1N1CCN(C(=O)N2CCN(C)CC2)CC1

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 2/20 0.77
DRD3 P35462 1/20 0.77
AKR1C3 P42330 1/20 0.75
HTR1A P08908 2/20 0.66
HTR1D P28221 2/20 0.66
HTR1B P28222 2/20 0.66
HTR2A P28223 2/20 0.66
HTR2C P28335 1/20 0.66
HTR7 P34969 1/20 0.66
HTR6 P50406 1/20 0.66
TSHR P16473 4/20 0.61
POLB P06746 3/20 0.60
MEN1 O00255 2/20 0.60
KMT2A Q03164 2/20 0.60
PKM P14618 1/20 0.60
HPGDS O60760 1/20 0.60
SMN1; SMN2 Q16637 2/20 0.58
ALDH1A1 P00352 5/20 0.58
CYP1A2 P05177 1/20 0.58
CYP3A4 P08684 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27829788 0.94 AKR1C3 (0.83) DRD2DRD3AKR1C3TSHRPOLB
SCHEMBL327835 0.87 DRD2 (1.00) DRD2DRD3HTR1AHTR1DHTR1B
Hydrochloric Acid SCHEMBL8576226 0.86 DRD2 (0.96) DRD2DRD3HTR1AHTR1DHTR1B
SCHEMBL16026545 0.84 PKM (0.74) DRD2DRD3AKR1C3TSHRPOLB
SCHEMBL8723365 0.84 TSHR (0.83) DRD2DRD3HTR1AHTR1DHTR1B
SCHEMBL3904994 0.83 KMT2A (0.68) DRD2DRD3AKR1C3HTR2ATSHR
SCHEMBL7793932 0.83 AKR1C3 (0.68) DRD2DRD3AKR1C3TSHRPOLB
SCHEMBL8362372 0.82 TSHR (0.68) DRD2DRD3AKR1C3TSHRPOLB
SCHEMBL6187316 0.82 DRD2 (0.81) DRD2DRD3HTR1AHTR1DHTR1B
SCHEMBL1423195 0.82 AKR1C3 (0.66) DRD2DRD3AKR1C3TSHRPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070249618-A1 Novel Piperidine Derivatives as Histamine H3 Receptor Ligands for Treatment of Depression ASTRAZENECA AB (SE) 2007-10-25 US disclosed
US-20070249618-A1 Novel Piperidine Derivatives as Histamine H3 Receptor Ligands for Treatment of Depression ASTRAZENECA AB (SE) 2007-10-25 US disclosed
US-20070249618-A1 Novel Piperidine Derivatives as Histamine H3 Receptor Ligands for Treatment of Depression ASTRAZENECA AB (SE) 2007-10-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070249618-A1 Novel Piperidine Derivatives as Histamine H3 Receptor Ligands for Treatment of Depression HRH3, HRH1, HRH4 DRD2 34/4885DRD3 78/4885AKR1C3 2719/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.